Boji Medical Technology Co.,Ltd. (SZSE: 300404)
Health Care · Life Sciences Tools & Services · CN
CN¥14.73
+2.01% today · +47.2% 1Y
Boji Medical Technology Co.,Ltd. (SZSE: 300404) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $841.23M.
Over the last twelve months the share price has gained 47.2%, trading between 8.15 and 17.99.
Tweenvest scores Boji Medical Technology Co.,Ltd. across four factors: quality 75/100, value 35/100, growth 78/100, dividend 40/100. Its strongest factor is growth.
300404 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $841.23M
- Revenue (TTM)
- $141.52M
- P/E
- 108.50
- EPS
- 0.14
- Dividend yield
- 0.09%
- Beta (5Y)
- 0.33
- 52-week high
- CN¥17.99
- 52-week low
- CN¥8.15
- Avg volume (3M)
- —
- Shares outstanding
- 383.08M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd.SHSE: 603108 | $898.64M | CN¥9.97 | -0.10% |
| Cryoport, Inc.NasdaqCM: CYRX | $882.81M | $16.90 | -3.04% |
| Maccura Biotechnology Co.LtdSZSE: 300463 | $859.07M | CN¥9.53 | +2.47% |
| Pacific Biosciences of California, Inc.NasdaqGS: PACB | $845.46M | $2.30 | -15.44% |
| Shanghai Obio Technology (Group) Corp., Ltd.SHSE: 688238 | $831.61M | CN¥8.85 | +3.87% |
| Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.SZSE: 301096 | $797.08M | CN¥49.30 | +2.22% |
| Ginkgo Bioworks Holdings, Inc.NYSE: DNA | $763.64M | $11.34 | -1.13% |
| Shanghai Model Organisms Center, Inc.SHSE: 688265 | $748.50M | CN¥64.98 | +24.65% |
Figures last refreshed Oct 4, 2026.